This course has expired. View available courses.
Oncology
Stepping forward in the pharmacological treatment of advanced renal cell carcinoma – Certificate of Completion
DURATION
PROFESSION
Specialist
# OF CREDITS
2
ACCREDITATION
Certificate of Completion
EXPIRY DATE
2018-07-08
Learning objectives
On completion of this program, participants will be better able to:
- recall the current clinical guideline recommendations for mRCC management
- discuss the mechanisms of action, indications, contra-indications, side effect profiles and Pharmaceutical Benefits Scheme (PBS) listing of first- and second-line therapies for metastatic renal cell carcinoma (mRCC)
- evaluate the evidence for efficacy and safety, as well as the health related quality of life (HRQoL) for first-line therapies both from clinical trials and real world data
- manage patients with mRCC including therapy initiation, ongoing clinical monitoring, assessment of efficacy and management of side effects and disease progression